India requires pragmatic compulsive licensing system: Cipla
Updated : March 06, 2019 08:17 PM IST
The industry doyen pointed out that 70 percent of the major drugs are in-licensed and it is what India should look to do.
He added that many drugs which are not covered under patent should be made in India which is not happening at present, citing example of Vitamin B12, Vitamin B6, Vitamin D, Vitamin C.
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morning
YOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more